Prevention of Th1 responses is critical for tolerance

Transplantation

Volumn 61, Issue 7, 1996, Pages 1076-1083

  Chen, Naixi ^a   Gao, Qinglin ^a   Field, Elizabeth H ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4;

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GRAFT REJECTION; HELPER CELL; IMMUNOLOGICAL TOLERANCE; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPH NODE CELL; MEMORY CELL; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN GRAFT; SPLEEN CELL; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; FEMALE; IMMUNOLOGY; NEWBORN; PHYSIOLOGY; TH1 CELL;

ANIMALS; ANIMALS, NEWBORN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; FEMALE; GRAFT REJECTION; IMMUNE TOLERANCE; INTERFERON TYPE II; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS;

EID: 0029664599     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199604150-00016     Document Type: Article

References (54)

1. Dallman MJ, Larsen CP, Morris PJ. Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med 1991; 174: 493.
2. O'Connell P, Pacheco-Silva A, Nickerson P, et al. Unmodified pancreatic islet allograft rejection results in the preferential expression of certain T cell activation transcripts. J Immunol 1993; 150: 1093.
3. Thai NL, Fu F, Qian S, et al. Cytokine mRNA profiles in mouse orthotopic liver transplantation: graft rejection is associated with augmented Th1 function. Transplantation 1995; 59: 274.
4. Takeuchi T, Lowry RP, Konieczny B. Heart allografts in murine systems. The differential activation of Th2-like effector cells in peripheral tolerance. Transplantation 1992; 53: 1281.
5. Mottram PL, Ham W-R, Purcell LJ, McKenzie IFC, Hancock WW. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-γ in long-surviving mouse heart allografts after brief CD4 monoclonal antibody therapy. Transplantation 1995; 59: 559.
6. Sayegh MH, Akalin E, Hancock WW, et al. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med 1995; 181: 1869.
7. Burgeon K, Cuturi M-C, Hallet J, Paineau J, Chabannes D, Soulillou J-P. Peripheral tolerance of an allograft in adult rats - characterization by low interleukin-2 and interferon-γ mRNA levels and by strong accumulation of major histocompatability complex transcripts in the graft. Transplantation 1992; 54: 219.
8. Hancock WW, Sayegh MH, Kwok CA, Weiner HL, Carpenter CB. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation. Transplantation 1993; 55: 1112.
9. + T cells in vivo. J Immunol 1992; 148: 1308.
10. Nickerson P, Pacheco-Sila A, O'Connell PJ, Steuer W, Kelley V, Strom TB. Analysis of cytokine transcripts in pancreatic islet cell allografts during rejection and tolerance induction. Transplant Proc 1993; 25: 984.
11. + T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection. Transplantation 1995; 59: 1155.
12. Krams SM, Falco DA, Villanueva JC, et al. Cytokine and T cell receptor gene expression at the site of allograft rejection. Transplantation 1992; 53: 151.
13. Whitehead BF, Stoehr C, Wu CJ, et al. Cytokine gene expression in human lung transplant recipients. Transplantation 1995; 59: 1155.
14. Cunningham DA, Dunn MJ, Yacoub MH, Rose ML. Local production of cytokines in the human cardiac allograft. Transplantation 1994; 57: 1333.
15. Chen N. Field EH. Enhanced type 2 diminished type 1 cytokines in neonatal tolerance. Transplantation 1995; 59: 933.
16. Hofmann WJ, Dufter C, Terness P, et al. Lack of preferential Th1/Th2 cytokine gene expression patterns in both α/β T-cell-tolerant and -rejecting rat cardiac allografts. Transplant Proc 1995; 27: 232.
17. Kusaka S, Grailer AP, Fechner JH, Burlingham WJ. Evidence for a possible Th2 bias in human renal transplant tolerance. Transplant Proc 1995; 27: 225.
18. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature 1953; 172: 603.
19. Streilein JW. Neonatal tolerance of H-2 alloantigens. Transplantation 1991; 52: 1.
20. + T cells from T cell receptor transgenic mice. J Exp Med 1992; 176: 1091.
21. Abehsira-Amar O, Gibert M, Joliy M, Theze J, Jankovic DL. IL-4 plays a dominant role in the differential development of Th0 into Th1 and Th2 cells. J Immunol 1992; 148: 3820.
22. O'Garra A, Murphy K. Role of cytokines in determining T-lymphocyte function. Curr Opin Immunol 1994; 6: 458.
23. Romani L, Mencacci A, Grohmann U, et al. Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis. J Exp Med 1992; 176: 19.
24. Swain SL, Weinberg AD, English M, Huston G. IL-4 and IFN-γ direct the development of distinct subsets of helper T cells. Fed Proc 1990; 4: 2020.
25. + T cells from αβ-TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFN-γ production is IFN-γ dependent. Int Immunol 1993: 5: 1119.
26. Scott P. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J Immunol 1991; 147: 3149.
27. Chatelain R, Varkila K, Coffman RL. IL-4 induces a Th2 response in Leishmania major-infected mice. J Immunol 1992; 148: 1182.
28. Belosevic M, Finbloom, DS, Van Der Meide PH, Slayter MV, Nacy CA. Administration of monoclonal anti-IFN-γ antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. J Immunol 1989; 143: 266.
29. Adkins B, Ghanei A, Hamilton K. Developmental regulation of IL-4, IL-2 and IFN-gamma production by murine peripheral T lymphocytes. J Immunol 1993; 151: 6617.
30. Chen N, Gao Q, Field EH. Expansion of memory Th2 cells over Th1 cells in neonatal primed mice. Transplantation 1995; 60(11): 1187.
31. Sullivan JD, Valois FW, Watson SW. Endotoxins: the limulus amoebocyte lysate system. In: Bernheimer AW, ed. Mechanisms in bacterial toxicology. New York: Wiley, 1976: 217.
32. Gao Q, Chen N, Field EH. CD4 Th2 cells do not functionally suppress CTL generation in neonatal tolerant mice. Transplantation 1995; 60(11): 1260.
33. Field EH, Rouse TM. Alloantigen priming after total lymphoid irradiation alters alloimmune cytokine responses. Transplantation 1995; 60: 695.
34. Rosenberg AS, Singer A. Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction. Annu Rev Immunol 1992; 10: 333.
35. Gajewski TF, Fitch FW. Antiproliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clone. J Immunol 1988; 140: 4245.
36. Tanaka T, Hu-Li J, Seder RA, Fazekas De St. Groth B, Paul WE. Interleukin 4 suppresses interleukin 2 and interferon γ production by naive T cells stimulated by accessory cell-dependent receptor engagement. Proc Natl Acad Sci USA 1993; 90: 5914.
37. Donckier V, Abramowicz D, Bruyns C, et al. IFN-γ prevents Th2 cell-mediated pathology after neonatal injection of semiallogenic spleen cells in mice. J Immunol 1994; 153: 2361.
38. Wood PJ, Cossens IA. The influence of allo-class II MHC-specific Th2 cells on the generation of CD4 and CD8 cytotoxic T cells to associated class I and class II MHC alloantigen. Clin Exp Immunol 1995; 100: 359.
39. - cells that make Th2 cytokines and help B cells. Science 1993; 260: 1802.
40. Croft M, Carter L, Swain SL, Dutton RW. Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J Exp Med 1994; 180: 1715.
41. Rosenberg A, Finbloom D, Maniero T, Van der Meide P, Singer A. Specific prolongation of MHC class II disparate skin allografts by in vivo administration of anti-IFN-γ monoclonal antibody. J Immunol 1990; 144: 4648.
42. Landolfo S, Cofano F, Giovarelli M, Prat M, Cavallo G, Forni G. Inhibition of interferon-gamma may suppress allograft reactivity by T lymphocytes in vitro and in vivo. Science 1985; 229: 176.
43. Lipman ML, Stevens AC, Bleackley RC, et al. The strong correlation of cytotoxic T lymphocyte-specific serine protease gene transcripts with renal allograft rejection. Transplantation 1992; 53: 73.
44. Lowry RP, Gurley KE, Forbes RD. Immune mechanisms in organ allograft rejection. I. Delayed-type hypersensitivity and lymphocytotoxicity in heart graft rejection. Transplantation 1983; 36: 391.
45. Lowry RP, Marghesco DM, Blackburn JH. Immune mechanisms in organ allograft rejection. VI. Delayed-type hypersensitivity and lymphotoxin in experimental renal allograft rejection. Transplantation 1985; 40: 183.
46. Ascher NL, Cahill DR, Hoffman RA, Simmons RL. Lymphocytes capable of mediating delayed-type hypersensitivity reactions accumulate within sponge matrix allografts. Surgery 1986; 100: 321.
47. + T cells. Transplantation 1992; 54: 278.
48. + cells: specificity and function. Immunol Rev 1988; 101: 39.
49. + T cells. Annu Rev Immunol 1994; 12: 653.
50. Abramowicz D, Vandervorst P, Bruyns C, Doutrelepont JM, Vandenabeele P, Goldman M. Persistence of anti-donor allohelper T cells after neonatal induction of allotolerance in mice. Eur J Immunol 1990; 20: 1647.
51. Skoskiewicz MJ, Colvin RB, Schneeberger EE, Russell PS. Widespread and selective induction of major histocompatability complex-determined antigens in vivo by gamma interferon. J Exp Med 1985; 162: 1645.
52. Gaspari AA, Katz SI. Induction and functional characterization of class II MHC (Ia) antigens on murine keratinocytes. J Immunol 1988; 140: 2956.
53. Vossen A, Tibbe G, Benner R, Savelkoul H. T-lymphocyte and cytokine-directed strategies for inhibiting skin allograft rejection in mice. Transplant Proc 1995; 27: 380.
54. Donckier V, Wissing M, Bruyns C, et al. Critical role of interleukin 4 in the induction of neonatal transplantation tolerance. Transplantation 1995; 59: 1571.